| TTNP | Titan Pharmaceuticals Inc (de) | $263000.00 | -99.91% |
| LEXX | Lexaria Bioscience Corp | $276997.00 | -99.91% |
| CELZ | Creative Medical Technology Holdings Inc | $307649.00 | -99.90% |
| BBLG | Bone Biologics Corp | $309386.00 | -99.89% |
| CURX | Curanex Pharmaceuticals Inc | $332644.00 | -99.89% |
| ORMP | Oramed Pharmaceuticals Inc | $502688.00 | -99.83% |
| TCRT | Alaunos Therapeutics Inc | $595000.00 | -99.80% |
| CDIO | Cardio Diagnostics Holdings Inc | $655972.00 | -99.78% |
| GRI | GRI Bio Inc | $794000.00 | -99.73% |
| BGMS | Bio Green Med Solution Inc | $804000.00 | -99.73% |
| XRTX | XORTX Therapeutics Inc | $863819.00 | -99.71% |
| NTRB | Nutriband Inc | $868447.00 | -99.71% |
| PULM | Pulmatrix Inc | $905000.00 | -99.69% |
| PBM | Psyence Biomedical Ltd | $943068.00 | -99.68% |
| PHIO | Phio Pharmaceuticals Corp | $950000.00 | -99.68% |
| LITS | Lite Strategy Inc | $952000.00 | -99.68% |
| XBIO | Xenetic Biosciences Inc | $958239.00 | -99.67% |
| DRMA | Dermata Therapeutics Inc | $1.05M | -99.64% |
| CVKD | Cadrenal Therapeutics Inc | $1.06M | -99.64% |
| NNVC | NanoViricides Inc | $1.10M | -99.63% |
| GDTC | CytoMed Therapeutics Ltd | $1.13M | -99.62% |
| VYNE | VYNE Therapeutics Inc | $1.24M | -99.58% |
| OGEN | Oragenics Inc | $1.31M | -99.56% |
| SILO | SILO Pharma Inc | $1.34M | -99.55% |
| ANIX | Anixa Biosciences Inc | $1.39M | -99.53% |
| SYBX | Synlogic Inc | $1.42M | -99.52% |
| TELO | Telomir Pharmaceuticals Inc | $1.43M | -99.52% |
| HOTH | Hoth Therapeutics Inc | $1.43M | -99.51% |
| CMMB | Chemomab Therapeutics Ltd | $1.48M | -99.50% |
| ANEB | Anebulo Pharmaceuticals, Inc. Common Stock | $1.49M | -99.50% |
| ADIL | Adial Pharmaceuticals Inc | $1.51M | -99.49% |
| KTTA | Pasithea Therapeutics Corp | $1.54M | -99.48% |
| KALA | Kala Bio Inc | $1.56M | -99.47% |
| ADXN | Addex Therapeutics Ltd | $1.60M | -99.46% |
| EPIX | Essa Pharma Inc | $1.60M | -99.46% |
| GLSI | Greenwich LifeSciences Inc | $1.62M | -99.45% |
| AZTR | Azitra Inc | $1.65M | -99.44% |
| KAPA | Kairos Pharma Ltd | $1.67M | -99.43% |
| LIXT | Lixte Biotechnology Holdings Inc | $1.69M | -99.43% |
| ALZN | Alzamend Neuro Inc | $1.86M | -99.37% |
| BIVI | BioVie Inc - Class A | $1.91M | -99.35% |
| PCSA | Processa Pharmaceuticals Inc | $1.98M | -99.33% |
| SXTP | 60 Degrees Pharmaceuticals Inc | $2.02M | -99.31% |
| REVB | Revelation Biosciences Inc | $2.06M | -99.30% |
| IMRN | Immuron Ltd | $2.06M | -99.30% |
| HIND | ReShape Lifesciences Inc | $2.14M | -99.27% |
| COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $2.21M | -99.25% |
| INDP | Indaptus Therapeutics Inc | $2.24M | -99.24% |
| INTS | Intensity Therapeutics Inc | $2.31M | -99.22% |
| EDSA | Edesa Biotech Inc | $2.36M | -99.20% |
| IBO | NYSE AMEX LISTED TEST STOCK FOR CTS CQS | $2.38M | -99.19% |
| ENTX | Entera Bio Ltd | $2.44M | -99.17% |
| GOVX | Geovax Labs Inc | $2.49M | -99.16% |
| EXOZ | Invizyne Technologies Inc | $2.49M | -99.15% |
| VIVS | VivoSim Labs Inc | $2.52M | -99.14% |
| ACXP | Acurx Pharmaceuticals Inc | $2.53M | -99.14% |
| LPCN | Lipocine Inc | $2.53M | -99.14% |
| NRSN | NeuroSense Therapeutics Ltd | $2.59M | -99.12% |
| MNPR | Monopar Therapeutics Inc | $2.59M | -99.12% |
| PTN | Palatin Technologies Inc | $2.63M | -99.11% |
| ATHE | Alterity Therapeutics Ltd | $2.65M | -99.10% |
| RNXT | RenovoRx Inc | $2.70M | -99.08% |
| KZR | Kezar Life Sciences Inc | $2.76M | -99.06% |
| BCDA | BioCardia Inc | $2.78M | -99.06% |
| ENSC | Ensysce Biosciences Inc | $2.84M | -99.04% |
| MTNB | Matinas Biopharma Holdings Inc | $2.85M | -99.03% |
| CMND | Clearmind Medicine Inc | $2.90M | -99.01% |
| LIMN | Liminatus Pharma Inc | $2.92M | -99.01% |
| NRXS | Neuraxis Inc | $3.00M | -98.98% |
| IGC | IGC Pharma Inc | $3.06M | -98.96% |
| ONCO | Onconetix Inc | $3.08M | -98.95% |
| ASBP | Aspire Biopharma Holdings Inc | $3.25M | -98.90% |
| MNOV | Medicinova Inc | $3.30M | -98.88% |
| COCP | Cocrystal Pharma Inc | $3.31M | -98.88% |
| FBLG | FibroBiologics Inc | $3.34M | -98.87% |
| GNPX | Genprex Inc | $3.38M | -98.85% |
| LSTA | Lisata Therapeutics Inc | $3.39M | -98.85% |
| BDRX | Biodexa Pharmaceuticals Plc | $3.39M | -98.85% |
| INAB | IN8bio Inc | $3.48M | -98.82% |
| GRCE | Acasti Pharma Inc | $3.60M | -98.78% |
| EQ | Equillium Inc | $3.60M | -98.78% |
| MRKR | Marker Therapeutics Inc | $3.64M | -98.77% |
| PPCB | Propanc Biopharma Inc | $3.66M | -98.76% |
| BNTC | Benitec Biopharma Inc | $3.67M | -98.75% |
| BRTX | BioRestorative Therapies Inc | $3.67M | -98.75% |
| ERNA | Ernexa Therapeutics Inc | $3.68M | -98.75% |
| LTRN | Lantern Pharma Inc | $3.78M | -98.72% |
| DRUG | Bright Minds Biosciences Inc | $3.83M | -98.70% |
| SNGX | Soligenix Inc | $3.83M | -98.70% |
| CANF | Can-Fite Biopharma Ltd | $3.92M | -98.67% |
| ICU | SeaStar Medical Holding Corp | $3.95M | -98.66% |
| APRE | Aprea Therapeutics Inc | $3.95M | -98.66% |
| SONN | Sonnet BioTherapeutics Holdings Inc | $4.10M | -98.61% |
| PHGE | BiomX Inc | $4.13M | -98.60% |
| NCEL | NLS Pharmaceutics Ltd | $4.20M | -98.58% |
| RLYB | Rallybio Corp | $4.20M | -98.58% |
| CDT | CDT Equity Inc | $4.27M | -98.55% |
| CLYM | Eliem Therapeutics Inc | $4.29M | -98.54% |
| COYA | Coya Therapeutics Inc | $4.30M | -98.54% |
| SLXN | Silexion Therapeutics Corp | $4.31M | -98.54% |
| CRVO | CervoMed Inc | $4.50M | -98.47% |
| SLRX | Decoy Therapeutics Inc | $4.55M | -98.46% |
| CNSP | Cns Pharmaceuticals Inc | $4.58M | -98.44% |
| GTBP | GT Biopharma Inc | $4.60M | -98.44% |
| CLDI | Calidi Biotherapeutics Inc | $4.66M | -98.42% |
| IMNN | Imunon Inc | $4.66M | -98.42% |
| CLGN | CollPlant Biotechnologies Ltd New | $4.70M | -98.40% |
| GANX | Gain Therapeutics Inc | $4.73M | -98.39% |
| XBIT | XBiotech Inc | $4.82M | -98.36% |
| APM | Aptorum Group Ltd - Class A | $4.90M | -98.34% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | $4.92M | -98.33% |
| CLRB | Cellectar Biosciences Inc | $5.06M | -98.28% |
| ACTU | Actuate Therapeutics Inc | $5.13M | -98.26% |
| LGVN | Longeveron Inc - Class A | $5.18M | -98.24% |
| NCNA | NuCana plc | $5.19M | -98.24% |
| MTVA | MetaVia Inc | $5.32M | -98.20% |
| NEUP | Neuphoria Therapeutics Inc | $5.39M | -98.17% |
| EPRX | Eupraxia Pharmaceuticals Inc | $5.70M | -98.06% |
| IKT | Inhibikase Therapeutics Inc | $5.71M | -98.06% |
| ANTX | AN2 Therapeutics Inc | $5.73M | -98.05% |
| ARTL | Artelo Biosciences Inc | $5.85M | -98.02% |
| OKUR | Reneo Pharmaceuticals Inc - Class A | $5.93M | -97.99% |
| PALI | Palisade Bio Inc | $5.95M | -97.98% |
| SPRO | Spero Therapeutics Inc | $6.09M | -97.93% |
| RVPH | Reviva Pharmaceuticals Holdings Inc | $6.12M | -97.92% |
| INMB | INmune Bio Inc | $6.19M | -97.90% |
| CGTX | Cognition Therapeutics Inc | $6.23M | -97.89% |
| STTK | Shattuck Labs Inc | $6.29M | -97.87% |
| AVXL | Anavex Life Sciences Corporation | $6.37M | -97.84% |
| ELAB | PMGC Holdings Inc | $6.45M | -97.81% |
| ONCT | Oncternal Therapeutics Inc | $6.45M | -97.81% |
| HURA | TuHURA Biosciences Inc | $6.51M | -97.79% |
| MREO | Mereo Biopharma Group Plc | $6.56M | -97.77% |
| CNTX | Context Therapeutics Inc | $6.66M | -97.74% |
| PMN | ProMIS Neurosciences Inc | $6.69M | -97.73% |
| JUNS | Jupiter Neurosciences Inc | $6.73M | -97.71% |
| SLS | SELLAS Life Sciences Group Inc | $6.76M | -97.70% |
| EVGN | Evogene Ltd | $6.81M | -97.69% |
| PTIX | Protagenic Therapeutics Inc | $6.82M | -97.68% |
| ABVC | ABVC BioPharma Inc | $6.90M | -97.66% |
| QNRX | Quoin Pharmaceuticals Ltd | $6.92M | -97.65% |
| SLGL | Sol-Gel Technologies Ltd | $7.11M | -97.59% |
| SGMT | Sagimet Biosciences Inc - Class A | $7.18M | -97.56% |
| THRD | Third Harmonic Bio Inc | $7.21M | -97.55% |
| RNTX | Rein Therapeutics Inc | $7.24M | -97.54% |
| ENVB | Enveric Biosciences Inc | $7.25M | -97.54% |
| KPRX | Kiora Pharmaceuticals Inc | $7.29M | -97.52% |
| ATOS | Atossa Therapeutics Inc | $7.46M | -97.47% |
| TRVI | Trevi Therapeutics Inc | $7.48M | -97.46% |
| MAIA | MAIA Biotechnology Inc | $7.56M | -97.43% |
| PSTV | Plus Therapeutics Inc | $7.96M | -97.30% |
| MBIO | Mustang Bio Inc | $7.99M | -97.29% |
| OKYO | OKYO Pharma Ltd - New | $8.06M | -97.26% |
| MBRX | Moleculin Biotech Inc | $8.18M | -97.22% |
| HYFT | MindWalk Holdings Corp | $8.19M | -97.22% |
| DYAI | Dyadic International Inc DE | $8.22M | -97.21% |
| KLTO | Klotho Neurosciences Inc Com | $8.27M | -97.19% |
| KLTOW | Klotho Neurosciences Inc Wt Exp | $8.27M | -97.19% |
| APVO | Aptevo Therapeutics Inc | $8.29M | -97.19% |
| IMRX | Immuneering Corp Class A | $8.29M | -97.19% |
| IBIO | iBio Inc | $8.30M | -97.18% |
| VERU | Veru Inc | $8.30M | -97.18% |
| TENX | Tenax Therapeutics Inc | $8.49M | -97.12% |
| PMVP | PMV Pharmaceuticals Inc | $8.60M | -97.08% |
| RZLT | Rezolute Inc | $8.63M | -97.07% |
| ESLA | Estrella Immunopharma Inc | $8.93M | -96.97% |
| CUE | Cue Biopharma Inc | $9.27M | -96.85% |
| ABP | Abpro Holdings, Inc Common Stock | $9.35M | -96.83% |
| GNLX | Genelux Corp | $9.45M | -96.79% |
| SER | AgeX Therapeutics Inc | $9.67M | -96.72% |
| CALC | CalciMedica Inc | $9.71M | -96.70% |
| APLM | Apollomics Inc - Class A | $9.90M | -96.64% |
| TPST | Tempest Therapeutics Inc | $9.93M | -96.63% |
| IMAB | I-Mab | $9.97M | -96.61% |
| BLTE | Belite Bio Inc | $10.07M | -96.58% |
| TRML | Tourmaline Bio Inc | $10.10M | -96.57% |
| XCUR | Exicure Inc | $10.12M | -96.57% |
| SKYE | Skye Bioscience Inc | $10.40M | -96.47% |
| EVAX | Evaxion Biotech A/S | $10.44M | -96.46% |
| MURA | Mural Oncology plc | $10.57M | -96.41% |
| TARA | Protara Therapeutics Inc | $10.71M | -96.36% |
| QNCX | Quince Therapeutics Inc | $10.95M | -96.28% |
| WHWK | Whitehawk Therapeutics Inc | $11.06M | -96.25% |
| NVCT | Nuvectis Pharma Inc | $11.18M | -96.21% |
| TRAW | Traws Pharma Inc | $11.25M | -96.18% |
| NXTC | Nextcure Inc | $11.26M | -96.18% |
| CTNM | Contineum Therapeutics Inc - Class A | $11.31M | -96.16% |
| TVRD | Cara Therapeutics Inc | $11.31M | -96.16% |
| IMMX | Immix Biopharma Inc | $11.45M | -96.11% |
| ELVN | Enliven Therapeutics Inc | $11.49M | -96.10% |
| HYPD | Eyenovia Inc | $11.57M | -96.07% |
| AARD | Aardvark Therapeutics Inc | $11.60M | -96.06% |
| RPTX | Repare Therapeutics Inc | $11.62M | -96.06% |
| ZURA | Zura Bio Ltd - Class A | $11.74M | -96.01% |
| CVM | Cel-Sci Corp | $11.76M | -96.01% |
| BCLI | Brainstorm Cell Therapeutics Inc | $11.76M | -96.01% |
| ACOG | Alpha Cognition Inc | $11.79M | -96.00% |
| GHRS | GH Research PLC | $11.89M | -95.96% |
| CING | Cingulate Inc | $12.00M | -95.93% |
| IFRX | InflaRx N.V. | $12.01M | -95.92% |
| ACRV | Acrivon Therapeutics Inc | $12.32M | -95.82% |
| DSGN | Design Therapeutics Inc | $12.39M | -95.79% |
| CRVS | Corvus Pharmaceuticals Inc | $12.52M | -95.75% |
| TTRX | Turn Therapeutics Inc | $12.53M | -95.75% |
| RNAZ | TransCode Therapeutics Inc | $12.64M | -95.71% |
| ANVS | Annovis Bio Inc | $13.12M | -95.55% |
| ONCY | Oncolytics Biotech Inc | $13.29M | -95.49% |
| IMA | Ikena Oncology Inc | $13.36M | -95.47% |
| FULC | Fulcrum Therapeutics Inc | $13.47M | -95.43% |
| RAPT | RAPT Therapeutics Inc | $13.76M | -95.33% |
| UPB | Upstream Bio Inc | $14.06M | -95.23% |
| VTGN | VistaGen Therapeutics Inc | $14.14M | -95.20% |
| SNSE | Sensei Biotherapeutics Inc | $14.19M | -95.18% |
| LPTX | Leap Therapeutics Inc | $14.32M | -95.14% |
| CRDF | Cardiff Oncology Inc | $14.46M | -95.09% |
| DWTX | Virios Therapeutics Inc | $14.58M | -95.05% |
| TVGN | Tevogen Bio Holdings Inc | $14.76M | -94.99% |
| LBRX | LB Pharmaceuticals Inc | $14.79M | -94.98% |
| ZVSA | ZyVersa Therapeutics Inc | $14.87M | -94.95% |
| MBX | MBX Biosciences Inc | $14.95M | -94.93% |
| ICCC | Immucell Corp | $14.97M | -94.92% |
| CBIO | Crescent Biopharma Inc | $15.28M | -94.81% |
| AIM | AIM ImmunoTech Inc. | $15.56M | -94.72% |
| TECX | AvroBio Inc | $16.16M | -94.51% |
| RANI | Rani Therapeutics Holdings Inc Class A | $16.34M | -94.45% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | $16.40M | -94.43% |
| PMCB | PharmaCyte Biotech Inc | $16.47M | -94.41% |
| NTHI | NeOnc Technologies Holdings Inc | $16.56M | -94.38% |
| RLMD | Relmada Therapeutics Inc | $16.63M | -94.35% |
| YDES | YD Bio Ltd | $16.64M | -94.35% |
| SION | Sionna Therapeutics Inc | $16.83M | -94.29% |
| CRIS | Curis Inc | $16.98M | -94.24% |
| ABUS | Arbutus Biopharma Corp | $16.99M | -94.23% |
| OSTX | OS Therapies Inc | $17.05M | -94.21% |
| QTTB | Q32 Bio Inc | $17.36M | -94.11% |
| CNTB | Connect Biopharma Holdings Ltd | $17.44M | -94.08% |
| BLRX | Bioline Rx Ltd | $17.56M | -94.04% |
| ORKA | ARCA biopharma Inc | $17.76M | -93.97% |
| JSPR | Jasper Therapeutics Inc | $17.78M | -93.96% |
| EVMN | Evommune Inc | $17.90M | -93.92% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | $18.14M | -93.84% |
| TERN | Terns Pharmaceuticals Inc | $18.55M | -93.70% |
| CMPX | Compass Therapeutics Inc | $18.70M | -93.65% |
| LXEO | Lexeo Therapeutics Inc | $18.86M | -93.60% |
| MPLT | MapLight Therapeutics Inc | $18.95M | -93.57% |
| MOLN | Molecular Partners AG | $19.15M | -93.50% |
| LNAI | Lunai Bioworks Inc | $19.41M | -93.41% |
| VTYX | Ventyx Biosciences Inc | $20.10M | -93.18% |
| ACHV | Achieve Life Sciences Inc | $20.27M | -93.12% |
| GRDX | Entero Therapeutics Inc | $20.47M | -93.05% |
| ADTX | Aditxt Inc | $20.66M | -92.99% |
| PDSB | PDS Biotechnology Corporation | $20.77M | -92.95% |
| ARTV | Artiva Biotherapeutics Inc | $20.97M | -92.88% |
| ORIC | ORIC Pharmaceuticals Inc | $21.20M | -92.80% |
| SABS | SAB Biotherapeutics Inc | $21.22M | -92.80% |
| SPRB | Spruce Biosciences Inc | $21.52M | -92.70% |
| HCWB | HCW Biologics Inc | $21.58M | -92.67% |
| FBRX | Forte Biosciences Inc | $21.79M | -92.60% |
| ATHA | Athira Pharma Inc | $22.29M | -92.43% |
| PEPG | PepGen Inc | $22.32M | -92.43% |
| AKTX | Akari Therapeutics Plc | $22.69M | -92.30% |
| TOVX | Theriva Biologics Inc | $22.85M | -92.24% |
| JBIO | Jade Biosciences Inc | $22.97M | -92.20% |
| VANI | Vivani Medical Inc | $23.27M | -92.10% |
| PHVS | Pharvaris NV | $23.48M | -92.03% |
| ABSI | Absci Corp | $23.62M | -91.98% |
| GLTO | Galecto Inc | $23.84M | -91.91% |
| CSBR | Champions Oncology Inc | $24.07M | -91.83% |
| ELTX | Elicio Therapeutics Inc | $24.13M | -91.81% |
| ALDX | Aldeyra Therapeutics Inc | $24.33M | -91.74% |
| CMRX | Chimerix Inc | $24.33M | -91.74% |
| TYRA | Tyra Biosciences Inc | $24.46M | -91.70% |
| PASG | Passage Bio Inc | $24.71M | -91.61% |
| GYRE | Gyre Therapeutics Inc | $25.03M | -91.50% |
| AVBP | ArriVent BioPharma Inc | $25.32M | -91.41% |
| EWTX | Edgewise Therapeutics Inc | $25.32M | -91.41% |
| NGNE | Neoleukin Therapeutics Inc | $25.36M | -91.39% |
| AEON | AEON Biopharma Inc - Class A | $25.38M | -91.38% |
| BRNS | Barinthus Biotherapeutics Plc. | $25.66M | -91.29% |
| PHXM | PHAXIAM Therapeutics SA ADR | $25.70M | -91.28% |
| NRXP | NRX Pharmaceuticals Inc | $25.72M | -91.27% |
| LENZ | LENZ Therapeutics Inc | $26.04M | -91.16% |
| RAPP | Rapport Therapeutics Inc | $26.09M | -91.15% |
| ADAG | Adagene Inc | $26.36M | -91.05% |
| KROS | Keros Therapeutics Inc | $26.66M | -90.95% |
| UNCY | Unicycive Therapeutics Inc | $26.70M | -90.94% |
| ALXO | Alx Oncology Holdings Inc | $26.98M | -90.84% |
| DARE | Dare Bioscience Inc | $27.09M | -90.80% |
| HLVX | HilleVax Inc | $27.09M | -90.80% |
| HOOK | Hookipa Pharma Inc | $27.18M | -90.78% |
| AVIR | Atea Pharmaceuticals Inc | $27.18M | -90.77% |
| OVID | Ovid Therapeutics Inc | $27.36M | -90.71% |
| BMEA | Biomea Fusion Inc | $27.67M | -90.61% |
| ALLR | Allarity Therapeutics Inc | $28.00M | -90.49% |
| BOLT | Bolt Biotherapeutics Inc | $28.20M | -90.43% |
| DRTS | Alpha Tau Medical Ltd | $28.55M | -90.31% |
| BDTX | Black Diamond Therapeutics Inc | $28.62M | -90.28% |
| TNYA | Tenaya Therapeutics Inc | $28.88M | -90.20% |
| VTVT | vTv Therapeutics Inc - Class A | $28.95M | -90.17% |
| SLRN | Acelyrin Inc | $29.27M | -90.06% |
| ACET | Adicet Bio Inc | $29.32M | -90.05% |
| YMAB | Y-Mabs Therapeutics Inc | $29.72M | -89.91% |
| SEER | Seer Inc - Class A | $30.65M | -89.60% |
| TNXP | Tonix Pharmaceuticals Holding Corp | $30.77M | -89.55% |
| OABI | OmniAb Inc | $31.00M | -89.48% |
| IMNM | Immunome Inc | $31.11M | -89.44% |
| PVLA | Palvella Therapeutics Inc | $31.45M | -89.33% |
| NAGE | Niagen Bioscience Inc | $32.00M | -89.14% |
| AURA | Aura Biosciences Inc | $32.52M | -88.96% |
| ALGS | Aligos Therapeutics Inc | $32.77M | -88.88% |
| ANRO | Alto Neuroscience Inc | $32.89M | -88.84% |
| PYXS | Pyxis Oncology Inc | $33.03M | -88.79% |
| PROK | ProKidney Corp - Class A | $33.27M | -88.71% |
| NAUT | Nautilus Biotechnology Inc | $33.36M | -88.67% |
| AVTX | Avalo Therapeutics Inc | $33.41M | -88.66% |
| FENC | Fennec Pharmaceuticals Inc | $34.15M | -88.41% |
| APLT | Applied Therapeutics Inc | $34.94M | -88.14% |
| PLX | Protalix BioTherapeutics Inc | $35.11M | -88.08% |
| SNTI | Senti Biosciences Inc | $35.68M | -87.89% |
| CGEM | Cullinan Oncology Inc | $36.81M | -87.50% |
| ASMB | Assembly Biosciences Inc | $36.90M | -87.48% |
| PRTA | Prothena Corporation plc | $37.28M | -87.35% |
| PLRX | Pliant Therapeutics Inc | $37.43M | -87.29% |
| APGE | Apogee Therapeutics Inc | $37.86M | -87.15% |
| IMUX | Immunic Inc | $38.51M | -86.93% |
| MDWD | MediWound Ltd | $38.56M | -86.91% |
| ATXS | Astria Therapeutics Inc | $38.61M | -86.89% |
| IVVD | Invivyd Inc | $38.69M | -86.87% |
| IOBT | IO Biotech Inc | $39.05M | -86.75% |
| LVTX | LAVA Therapeutics NV | $39.23M | -86.68% |
| CTMX | CytomX Therapeutics Inc | $39.41M | -86.62% |
| BCAX | Bicara Therapeutics Inc | $39.64M | -86.54% |
| ITRM | Iterum Therapeutics Plc | $39.88M | -86.46% |
| SAVA | Cassava Sciences Inc. | $40.23M | -86.35% |
| NBY | Stablecoin Development Corp | $40.92M | -86.11% |
| KLRS | Kalaris Therapeutics Inc | $41.25M | -86.00% |
| PTGX | Protagonist Therapeutics Inc | $41.99M | -85.75% |
| ATNM | Actinium Pharmaceuticals Inc | $43.13M | -85.36% |
| CGON | Cg Oncology Inc | $43.48M | -85.24% |
| INO | Inovio Pharmaceuticals Inc | $43.71M | -85.16% |
| TNGX | Tango Therapeutics Inc | $44.29M | -84.97% |
| OSRH | Bellevue Life Sciences Acquisition Corp | $44.80M | -84.79% |
| CABA | Cabaletta Bio Inc | $44.84M | -84.78% |
| JAGX | Jaguar Health Inc | $45.11M | -84.69% |
| BBOT | BridgeBio Oncology Therapeutics Inc Com | $45.37M | -84.60% |
| DNTH | Dianthus Therapeutics Inc | $45.57M | -84.53% |
| SVRA | Savara Inc | $45.61M | -84.52% |
| VYGR | Voyager Therapeutics Inc | $45.66M | -84.50% |
| MENS | Jyong Biotech Ltd | $45.68M | -84.49% |
| ENTO | Entero Therapeutics, Inc. Common Stock | $45.81M | -84.45% |
| HOWL | Werewolf Therapeutics Inc | $45.82M | -84.45% |
| BCAB | BioAtla Inc | $45.88M | -84.43% |
| ABOS | Acumen Pharmaceuticals Inc | $46.15M | -84.33% |
| ELDN | Eledon Pharmaceuticals Inc | $46.21M | -84.31% |
| LYRA | Lyra Therapeutics Inc | $46.83M | -84.11% |
| CRBU | Caribou Biosciences Inc | $46.98M | -84.05% |
| OCS | Oculis Holding AG | $47.20M | -83.98% |
| RCKT | Rocket Pharmaceuticals Inc | $47.37M | -83.92% |
| CAPR | Capricor Therapeutics Inc | $47.58M | -83.85% |
| AKRO | Akero Therapeutics Inc | $47.94M | -83.73% |
| IMMP | Immutep Ltd | $48.30M | -83.60% |
| STOK | Stoke Therapeutics Inc | $48.40M | -83.57% |
| BYSI | BeyondSpring Inc | $48.76M | -83.45% |
| SLDB | Solid Biosciences Inc | $48.76M | -83.45% |
| XENE | Xenon Pharmaceuticals Inc | $48.99M | -83.37% |
| OBIO | Orchestra BioMed Holdings Inc | $49.69M | -83.13% |
| OLMA | Olema Pharmaceuticals Inc | $50.17M | -82.97% |
| PRAX | Praxis Precision Medicines Inc | $50.24M | -82.95% |
| LRMR | Larimar Therapeutics Inc | $50.48M | -82.87% |
| OTLK | Outlook Therapeutics Inc | $50.89M | -82.73% |
| OCGN | Ocugen Inc | $51.10M | -82.65% |
| ABEO | Abeona Therapeutics Inc | $53.55M | -81.82% |
| ARCT | Arcturus Therapeutics Holdings Inc | $54.05M | -81.65% |
| BOLD | Boundless Bio Inc | $54.59M | -81.47% |
| CLDX | Celldex Therapeutics Inc | $55.03M | -81.32% |
| ALT | Altimmune Inc | $55.04M | -81.32% |
| ACRS | Aclaris Therapeutics Inc | $55.07M | -81.31% |
| ENGN | enGene Holdings Inc | $55.57M | -81.14% |
| LCTX | Lineage Cell Therapeutics Inc | $56.84M | -80.71% |
| ATRA | Atara Biotherapeutics Inc | $57.31M | -80.55% |
| RLAY | Relay Therapeutics Inc | $57.43M | -80.51% |
| EYPT | EyePoint Pharmaceuticals Inc | $57.74M | -80.40% |
| RNA | Atrium Therapeutics Inc | $58.26M | -80.23% |
| ANNX | Annexon Inc | $58.35M | -80.19% |
| DBVT | DBV Technologies | $58.40M | -80.18% |
| MGX | Metagenomi Inc | $59.17M | -79.92% |
| PRLD | Prelude Therapeutics Inc | $59.46M | -79.82% |
| GPCR | Structure Therapeutics Inc | $61.03M | -79.28% |
| FDMT | 4D Molecular Therapeutics Inc | $61.07M | -79.27% |
| KYTX | Kyverna Therapeutics Inc | $61.44M | -79.14% |
| PRQR | ProQR Therapeutics N.V | $61.50M | -79.12% |
| IRON | Disc Medicine Inc | $61.78M | -79.03% |
| IPSC | Century Therapeutics Inc | $61.81M | -79.02% |
| CASI | CASI Pharmaceuticals Inc | $62.93M | -78.64% |
| CTXR | Citius Pharmaceuticals Inc | $63.46M | -78.46% |
| CADL | Candel Therapeutics Inc | $63.89M | -78.31% |
| KRRO | Korro Bio Inc | $63.99M | -78.28% |
| PBYI | Puma Biotechnology Inc | $64.28M | -78.18% |
| TRDA | Entrada Therapeutics Inc | $64.66M | -78.05% |
| CLSD | Clearside Biomedical, Inc. Common Stock | $65.59M | -77.74% |
| SLN | Silence Therapeutics Plc | $65.72M | -77.69% |
| MDXG | Mimedx Group Inc | $65.74M | -77.68% |
| LXRX | Lexicon Pharmaceuticals Inc | $65.96M | -77.61% |
| ATAI | ATAI Life Sciences N.V. | $66.10M | -77.56% |
| DAWN | Day One Biopharmaceuticals Inc | $66.67M | -77.37% |
| NAMS | NewAmsterdam Pharma Company NV | $67.42M | -77.11% |
| ERAS | Erasca Inc | $67.71M | -77.02% |
| DTIL | Precision Biosciences Inc | $67.79M | -76.99% |
| ZNTL | Zentalis Pharmaceuticals Inc | $70.39M | -76.11% |
| GBIO | Generation Bio Company | $71.34M | -75.79% |
| WVE | Wave Life Sciences Ltd | $71.81M | -75.62% |
| ZVRA | Zevra Therapeutics Inc | $72.78M | -75.30% |
| CAMP | CAMP4 Therapeutics Corp | $74.56M | -74.69% |
| AGIO | Agios Pharmaceuticals Inc | $75.88M | -74.24% |
| LYEL | Lyell Immunopharma Inc | $76.96M | -73.88% |
| GUTS | Fractyl Health Inc | $78.01M | -73.52% |
| MAZE | Maze Therapeutics Inc | $78.01M | -73.52% |
| SGMO | Sangamo Therapeutics Inc | $78.92M | -73.21% |
| NMRA | Neumora Therapeutics Inc | $83.20M | -71.76% |
| IPHA | Innate Pharma | $84.39M | -71.36% |
| VXRT | Vaxart Inc | $85.94M | -70.83% |
| CDXS | Codexis Inc | $86.14M | -70.76% |
| NKTX | Nkarta Inc | $86.21M | -70.74% |
| JANX | Janux Therapeutics Inc | $86.69M | -70.57% |
| IMTX | Immatics N.V | $87.55M | -70.28% |
| IRD | Ocuphire Pharma Inc | $87.89M | -70.17% |
| TSHA | Taysha Gene Therapies Inc | $88.41M | -69.99% |
| TIL | Instil Bio Inc | $89.73M | -69.54% |
| XLO | Xilio Therapeutics Inc | $90.94M | -69.13% |
| MCRB | Seres Therapeutics Inc | $91.12M | -69.07% |
| IDYA | Ideaya Biosciences Inc | $93.08M | -68.40% |
| SYRE | Spyre Therapeutics Inc | $93.14M | -68.38% |
| CCCC | C4 Therapeutics Inc | $94.61M | -67.88% |
| CDTX | Cidara Therapeutics Inc | $96.26M | -67.32% |
| BCYC | Bicycle Therapeutics Plc | $98.08M | -66.71% |
| HUMA | Humacyte Inc | $98.93M | -66.42% |
| XFOR | X4 Pharmaceuticals Inc | $101.83M | -65.43% |
| SMMT | Summit Therapeutics Inc | $101.92M | -65.40% |
| IMVT | Immunovant Inc | $104.42M | -64.55% |
| ALMS | Alumis Inc | $104.57M | -64.51% |
| RIGL | Rigel Pharmaceuticals | $104.71M | -64.46% |
| ACIU | AC Immune SA | $105.89M | -64.06% |
| VKTX | Viking Therapeutics Inc | $106.33M | -63.91% |
| PTHS | Channel Therapeutics Corporation | $110.28M | -62.57% |
| SLNO | Soleno Therapeutics Inc | $112.59M | -61.78% |
| THAR | Tharimmune Inc | $114.86M | -61.01% |
| ALLO | Allogene Therapeutics Inc | $117.08M | -60.26% |
| ABVX | Abivax | $117.55M | -60.10% |
| TCRX | Tscan Therapeutics Inc | $118.20M | -59.88% |
| PGEN | Precigen Inc | $118.39M | -59.81% |
| FGEN | FibroGen Inc | $118.92M | -59.63% |
| KRYS | Krystal Biotech Inc | $120.24M | -59.19% |
| CRNX | Crinetics Pharmaceuticals Inc | $120.68M | -59.04% |
| VERA | Vera Therapeutics Inc - Class A | $122.04M | -58.57% |
| MRSN | Mersana Therapeutics Inc | $122.22M | -58.51% |
| MNMD | Mind Medicine (MindMed) Inc. Common Shares | $122.44M | -58.44% |
| REPL | Replimune Group Inc | $123.05M | -58.23% |
| ADVM | Adverum Biotechnologies Inc | $128.05M | -56.53% |
| MRUS | Merus N.V | $129.26M | -56.12% |
| KYMR | Kymera Therapeutics Inc | $129.38M | -56.08% |
| VCEL | Vericel Corp | $129.40M | -56.08% |
| CPRX | Catalyst Pharmaceuticals Inc | $134.91M | -54.20% |
| NTLA | Intellia Therapeutics Inc | $137.84M | -53.21% |
| EDIT | Editas Medicine Inc | $144.93M | -50.80% |
| CELU | Celularity Inc - Class A | $145.39M | -50.65% |
| GALT | Galectin Therapeutics Inc | $146.00M | -50.44% |
| VSTM | Verastem Inc | $146.03M | -50.43% |
| MLTX | MoonLake Immunotherapeutics - Class A | $146.35M | -50.32% |
| OCUL | Ocular Therapeutix Inc | $150.96M | -48.76% |
| NBTX | Nanobiotix | $152.24M | -48.32% |
| VNDA | Vanda Pharmaceuticals Inc | $152.76M | -48.15% |
| CNTA | Centessa Pharmaceuticals plc | $154.41M | -47.58% |
| FBIO | Fortress Biotech Inc | $154.50M | -47.56% |
| NRIX | Nurix Therapeutics Inc | $155.24M | -47.31% |
| AUPH | Aurinia Pharmaceuticals Inc | $156.37M | -46.92% |
| NUVL | Nuvalent Inc - Class A | $156.78M | -46.78% |
| MIST | Milestone Pharmaceuticals Inc | $157.69M | -46.47% |
| XOMA | XOMA Corp | $158.96M | -46.04% |
| GLPG | Galapagos NV | $170.58M | -42.10% |
| CORT | Corcept Therapeutics Inc | $176.89M | -39.95% |
| PRTC | PureTech Health plc American Depositary Shares | $184.22M | -37.47% |
| NKTR | Nektar Therapeutics | $187.06M | -36.51% |
| MESO | Mesoblast Ltd | $187.24M | -36.44% |
| CHRS | Coherus Biosciences Inc | $187.40M | -36.39% |
| IVA | Inventiva | $187.87M | -36.23% |
| SEPN | Septerna Inc | $191.23M | -35.09% |
| KOD | Kodiak Sciences Inc | $193.91M | -34.18% |
| MGNX | Macrogenics Inc | $196.68M | -33.24% |
| ENTA | Enanta Pharmaceuticals Inc | $198.12M | -32.75% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | $201.59M | -31.57% |
| ACLX | Arcellx Inc | $201.64M | -31.55% |
| IOVA | Iovance Biotherapeutics Inc | $203.91M | -30.78% |
| RYTM | Rhythm Pharmaceuticals Inc | $204.70M | -30.52% |
| INBX | Inhibrx Biosciences Inc | $205.00M | -30.41% |
| VIR | Vir Biotechnology Inc | $212.82M | -27.76% |
| GLUE | Monte Rosa Therapeutics Inc | $214.51M | -27.19% |
| DYN | Dyne Therapeutics Inc | $214.90M | -27.06% |
| PRME | Prime Medicine Inc | $218.03M | -25.99% |
| PHAR | Pharming Group N.V. | $220.41M | -25.18% |
| XNCR | Xencor Inc | $221.21M | -24.91% |
| SPRY | ARS Pharmaceuticals Inc | $226.26M | -23.20% |
| CLLS | Cellectis | $229.27M | -22.18% |
| ALEC | Alector Inc | $229.53M | -22.09% |
| TARS | Tarsus Pharmaceuticals Inc | $232.18M | -21.19% |
| HRTX | Heron Therapeutics Inc | $237.08M | -19.53% |
| SANA | Sana Biotechnology Inc | $254.35M | -13.66% |
| SRRK | Scholar Rock Holding Corp | $259.24M | -12.00% |
| ARVN | Arvinas Inc | $260.70M | -11.51% |
| CVAC | CureVac N.V. | $267.39M | -9.24% |
| ARQT | Arcutis Biotherapeutics Inc | $270.36M | -8.23% |
| ADMA | Adma Biologics Inc | $274.86M | -6.70% |
| CBUS | Cibus Global Ltd. Class A | $288.72M | -2.00% |
| GOSS | Gossamer Bio Inc | $290.38M | -1.43% |
| NUVB | Nuvation Bio Inc - Class A | $290.68M | -1.33% |
| COGT | Cogent Biosciences Inc | $295.31M | +0.24% |
| VALN | Valneva SE | $295.31M | +0.24% |
| FHTX | Foghorn Therapeutics Inc | $298.57M | +1.35% |
| MGTX | MeiraGTx Holdings plc | $302.79M | +2.78% |
| GERN | Geron Corp | $305.01M | +3.53% |
| STRO | Sutro Biopharma Inc | $308.88M | +4.85% |
| OPT | Opthea Ltd | $314.48M | +6.75% |
| ZYME | Zymeworks BC Inc | $314.63M | +6.80% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | $314.75M | +6.84% |
| BEAM | Beam Therapeutics Inc | $316.36M | +7.39% |
| RGNX | Regenxbio Inc | $320.81M | +8.90% |
| BHVN | Biohaven Ltd | $336.91M | +14.36% |
| DNLI | Denali Therapeutics Inc | $339.93M | +15.39% |
| NERV | Minerva Neurosciences Inc | $343.08M | +16.46% |
| KALV | KalVista Pharmaceuticals Inc | $348.57M | +18.32% |
| PCVX | Vaxcyte Inc | $352.29M | +19.58% |
| ARDX | Ardelyx Inc | $355.88M | +20.80% |
| CELC | Celcuity Inc | $356.64M | +21.06% |
| ACAD | Acadia Pharmaceuticals Inc | $357.16M | +21.24% |
| HRMY | Harmony Biosciences Holdings Inc | $361.48M | +22.70% |
| ABCL | AbCellera Biologics Inc | $369.03M | +25.26% |
| URGN | UroGen Pharma Ltd | $377.94M | +28.29% |
| CRMD | CorMedix Inc | $378.59M | +28.51% |
| ARMP | Armata Pharmaceuticals Inc | $381.39M | +29.46% |
| ENLV | Enlivex Therapeutics Ltd | $392.05M | +33.08% |
| KPTI | Karyopharm Therapeutics Inc | $397.06M | +34.78% |
| SRZN | Surrozen Inc | $398.86M | +35.39% |
| ZBIO | Zenas Biopharma Inc | $411.85M | +39.80% |
| ROIV | Roivant Sciences Ltd | $416.27M | +41.30% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | $417.33M | +41.66% |
| AUTL | Autolus Therapeutics plc | $418.24M | +41.97% |
| SNDX | Syndax Pharmaceuticals Inc | $431.05M | +46.32% |
| ZLAB | Zai Lab Ltd | $433.76M | +47.24% |
| RNAC | Cartesian Therapeutics Inc | $436.51M | +48.17% |
| TVTX | Travere Therapeutics Inc | $456.46M | +54.94% |
| ADCT | Adc Therapeutics SA | $507.87M | +72.39% |
| LGND | Ligand Pharmaceuticals Inc - Class B | $534.78M | +81.53% |
| KURA | Kura Oncology Inc | $544.67M | +84.88% |
| CAI | Caris Life Sciences Inc - Class A | $568.90M | +93.11% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | $589.92M | +100.25% |
| RVNC | Revance Therapeutics Inc | $624.59M | +112.01% |
| LEGN | Legend Biotech Corp | $629.02M | +113.52% |
| QURE | uniQure N.V. | $629.36M | +113.63% |
| PHAT | Phathom Pharmaceuticals Inc | $642.08M | +117.95% |
| MIRM | Mirum Pharmaceuticals Inc | $648.42M | +120.10% |
| VOR | Vor Biopharma Inc | $657.17M | +123.07% |
| EXEL | Exelixis Inc | $657.85M | +123.30% |
| AXSM | Axsome Therapeutics Inc | $659.02M | +123.70% |
| APLS | Apellis Pharmaceuticals Inc | $667.61M | +126.62% |
| FOLD | Amicus Therapeutics Inc | $675.63M | +129.34% |
| IMCR | Immunocore Holdings plc | $678.42M | +130.29% |
| MDGL | Madrigal Pharmaceuticals Inc | $683.87M | +132.14% |
| RCUS | Arcus Biosciences Inc | $695.12M | +135.95% |
| RVMD | Revolution Medicines Inc | $753.82M | +155.88% |
| MNKD | Mannkind Corp | $803.60M | +172.78% |
| NBP | NovaBridge Biosciences. | $894.81M | +203.74% |
| CRSP | CRISPR Therapeutics AG | $911.26M | +209.32% |
| TGTX | TG Therapeutics Inc | $945.71M | +221.01% |
| TLX | Telix Pharmaceuticals Ltd | $1.15B | +289.90% |
| NVAX | Novavax Inc | $1.19B | +303.23% |
| ARGX | Argen X SE | $1.36B | +361.51% |
| INSM | Insmed Inc | $1.37B | +365.38% |
| IBRX | ImmunityBio Inc | $1.52B | +414.52% |
| ASND | Ascendis Pharma A/S | $1.52B | +414.90% |
| RARE | Ultragenyx Pharmaceutical Inc | $1.52B | +417.65% |
| SRPT | Sarepta Therapeutics Inc | $1.67B | +468.17% |
| INCY | Incyte Corp | $1.72B | +482.58% |
| SVA | Sinovac Biotech Ltd | $2.04B | +593.77% |
| CYTK | Cytokinetics Inc | $2.10B | +612.85% |
| FTRE | FORTE SOFTWARE INC | $2.16B | +632.35% |
| BNTX | BioNTech SE | $2.38B | +707.46% |
| BMRN | Biomarin Pharmaceutical Inc | $2.38B | +707.50% |
| HALO | Halozyme Therapeutics Inc | $2.45B | +732.68% |
| AAPG | Ascentage Pharma Group International | $2.63B | +793.09% |
| IONS | Ionis Pharmaceuticals Inc | $2.96B | +904.26% |
| PTCT | PTC Therapeutics Inc | $3.05B | +935.16% |
| BBIO | BridgeBio Pharma Inc | $3.64B | +1135.52% |
| ONC | BeiGene Ltd | $3.79B | +1187.57% |
| MRNA | Moderna Inc | $4.08B | +1284.93% |
| ALNY | Alnylam Pharmaceuticals Inc | $4.18B | +1317.91% |
| GMAB | Genmab | $6.69B | +2172.20% |
| VRTX | Vertex Pharmaceuticals Inc | $7.12B | +2317.68% |
| REGN | Regeneron Pharmaceuticals Inc | $9.45B | +3106.11% |
| RPRX | Royalty Pharma plc - Class A | $9.88B | +3253.22% |